Trump administration proposes 340B pilot initiative to address controversy

Taking stock of the drug industry, from the lab to the medicine chest

July 31, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Trump administration proposes pilot initiative to address controversy over 340B drug discount program Hospital groups complained that any move toward offering rebates instead of upfront discounts would financially squeeze some participants. By Ed Silverman Trump escalates demands that pharma companies lower their drug prices Trump demanded, once again, that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the directive. By Elaine Chen STAT+ | Lilly's diabetes drug Mounjaro matches heart benefit of older treatment The newly released data should "strengthen the overall portrait" of the therapy, a company executive says. By Elaine Chen Molly Ferguson/STAT STAT+ | Are we sure Vinay Prasad's ouster is positive for biotech? It's hard not to see Prasad's exit as a complete and total victory for Sarepta Therapeutics, Adam Feuerstein writes. By Adam Feuerstein STAT+ | Alnylam raises revenue outlook as heart drug sees quick uptake The company's earnings report had been highly anticipated as a sign of therapy's competitiveness vs. a BridgeBio medication. By Elaine Chen STAT+ | Moderna lays off 10% of workforce in further cost-cutting move The company, facing government and competitive challenges, said job cuts were necessary in order for it to achieve its budget targets. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser